Search Results - "McGirr, Crystal"
-
1
Oncostatin M regulates hematopoietic stem cell (HSC) niches in the bone marrow to restrict HSC mobilization
Published in Leukemia (01-02-2022)“…We show that pro-inflammatory oncostatin M (OSM) is an important regulator of hematopoietic stem cell (HSC) niches in the bone marrow (BM). Treatment of…”
Get full text
Journal Article -
2
Bacterial Lipopolysaccharides Suppress Erythroblastic Islands and Erythropoiesis in the Bone Marrow in an Extrinsic and G- CSF-, IL-1-, and TNF-Independent Manner
Published in Frontiers in immunology (06-10-2020)“…Anemia of inflammation (AI) is the second most prevalent anemia after iron deficiency anemia and results in persistent low blood erythrocytes and hemoglobin,…”
Get full text
Journal Article -
3
An Immunoregulatory Role for Complement Receptors in Murine Models of Breast Cancer
Published in Antibodies (Basel) (08-01-2021)“…The complement system has demonstrated roles in regulating tumor growth, although these may differ between tumor types. The current study used two murine…”
Get full text
Journal Article -
4
Macrophage Involvement in the Response of Acute Myeloid Leukaemia to Chemotherapy
Published in Blood (08-12-2017)“…Acute myeloid leukemia (AML) is a clonally heterogeneous neoplasm with poor survival rates. Although chemotherapy often leads to clinical remission, the…”
Get full text
Journal Article -
5
Oncostatin M Is a Novel Niche Factor That Restrains Hematopoietic Stem Cell Mobilization in Response to G-CSF and CXCR4 Antagonist Plerixafor
Published in Blood (13-11-2019)“…Granulocyte colony-stimulating factor (G-CSF) and the CXCR4 chemokine receptor antagonist Plerixafor are used to mobilize hematopoietic stem and progenitor…”
Get full text
Journal Article -
6
Imaging flow cytometry reveals that granulocyte colony-stimulating factor treatment causes loss of erythroblastic islands in the mouse bone marrow
Published in Experimental hematology (01-02-2020)“…•Nine-channel imaging flow cytometry can quantitate EBIs.•Most cell aggregates co-expressing macrophage and erythroblast markers are not EBIs.•EBI central…”
Get full text
Journal Article -
7
Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes
Published in Blood (24-04-2014)“…The MYB oncogene is widely expressed in acute leukemias and is important for the continued proliferation of leukemia cells, suggesting that MYB may be a…”
Get full text
Journal Article -
8
ERYTHROPOIESIS SUPPRESSION BY BACTERIAL LIPOSACCHARIDES IS EXTRINSICALLY MEDIATED INDEPENDENTLY OF G-CSF
Published in Experimental hematology (01-08-2019)“…The central macrophage (MΦ) in erythroblastic islands (EI) is critical to erythropoiesis by providing iron and growth factors, and mediating enucleation of the…”
Get full text
Journal Article -
9
3002 – ONCOSTATIN M IS A NOVEL NICHE FACTOR THAT RESTRAINS HAEMATOPOIETIC STEM CELL MOBILISATION IN RESPONSE TO G-CSF AND CXCR4 ANTAGONIST PLERIXAFOR
Published in Experimental hematology (01-08-2021)“…Here we show that the pro-inflammatory cytokine oncostatin M (OSM) is an important regulator of haematopoietic stem cell (HSC) niches in the bone marrow (BM)…”
Get full text
Journal Article -
10
MYB down-regulation enhances sensitivity of U937 myeloid leukemia cells to the histone deacetylase inhibitor LBH589 in vitro and in vivo
Published in Cancer letters (01-02-2014)“…Highlights • Inducible shRNA-mediated MYB knockdown suppresses growth of U937 leukaemia cells in vitro and in vivo. • MYB knockdown sensitises U937 cells to…”
Get full text
Journal Article -
11
Suppression of Medullar Erythropoiesis in Response to Bacterial Lipopolysaccharides (LPS) Involves Two Distinct TLR4-Dependent Mechanisms with Contrasted Requirements for G-CSF Receptors
Published in Blood (02-12-2016)“…Erythropoiesis is a highly controlled process partly regulated in erythroblastic islands by the central erythroblastic island macrophage (EI MΦ) which provides…”
Get full text
Journal Article -
12
MYB down-regulation enhances sensitivity of U937 myeloid leukemia cells to the histone deacetylase inhibitor LBH589in vitroandin vivo
Published in Cancer letters (01-02-2014)“…The effect of combiningMYBsuppression with the histone deacetylase inhibitor LBH589 was studied in human myeloid leukemia cell lines.MYBknockdown inhibited…”
Get full text
Journal Article -
13
-
14
Autophagy prevents graft failure during murine graft-versus-host disease
Published in Blood advances (23-04-2024)“…•HSC increase autophagy in response to mitochondrial stress and cytokine stimulation with IL-1β and TNF identified as key inducers.•HSC and HPC require…”
Get full text
Journal Article -
15
HIF prolyl hydroxylase inhibitor FG-4497 enhances mouse hematopoietic stem cell mobilization via VEGFR2/KDR
Published in Blood advances (12-02-2019)“…In normoxia, hypoxia-inducible transcription factors (HIFs) are rapidly degraded within the cytoplasm as a consequence of their prolyl hydroxylation by…”
Get full text
Journal Article -
16
Interaction of c-Myb with p300 Is Required for the Induction of Acute Myeloid Leukemia by Human AML Oncogenes, and Represents a Potential Therapeutic Target
Published in Blood (16-11-2012)“…Abstract 2402 The MYB oncogene is widely expressed in acute leukaemias and is important for the continued proliferation of leukemia cells, raising the…”
Get full text
Journal Article -
17
Abstract A17: The dual angiogenesis/heparanase inhibitor PG545 inhibits solid tumor progression in models of breast, prostate and liver cancer: A comparative assessment of once versus twice weekly administration schedules
Published in Molecular cancer therapeutics (10-12-2009)“…Abstract PG545 is Progen's lead oncology candidate currently undergoing formal preclinical development. PG545 is a synthetic heparan sulfate (HS) mimetic that…”
Get full text
Journal Article